Company Long-Term Loans and Borrowings: Gilead Sciences Inc (GILD)

Public company logo of Gilead Corp (GILD)

Gilead Sciences, Inc. (GILD) is expanding its oncology presence, strengthening its status as a leader in antiviral therapy through acquisitions. Global diversification of component synthesis protects supplies from crises, ensuring profitability. The company's long-term debt metric reflects the dynamics of its liabilities, where the value 24.62 captures the current level. US centers support business stability by creating high-margin drugs to combat socially significant diseases.

GILD Gilead Sciences, Inc. Company Long-Term Debts (07/04/2022 - 11/01/2026)

Gilead Sciences Inc - analytical breakdowns and key metrics (GILD)

- market price and analyst price targets:
Stock Price gilead.com|GILD - Price Target Chart
- company stock exchange capitalization indicators:
Market Value Gilead Sciences|GILD - Total Company Value
- book capitalization information:
Accounting Value per Share Gilead Sciences|GILD - Book Capitalization|Market Capitalization to Book Value Ratio gilead.com|GILD - Cumulative Company Assets
- debt level and financial liquidity data:
All Debt to Shareholders' Equity Ratio Gilead Sciences, Inc.|GILD - Long-Term Debt to Equity Ratio|Short-Term Debt to Equity Gilead Corp|GILD - Company Aggregate Debts|Debts to Net Assets Gilead Sciences|GILD - Company Long-Term Debt|Company Short-Term Loans and Borrowings Gilead Sciences|Quick Ratio gilead.com
- earnings and multiples data:
GILD - Company Net Income
Summary company analytics:GILD gilead.com
Brand item of Gilead Corp

Long-term debt represents the aggregate of credit obligations with a maturity exceeding one year. This metric is calculated by summing all non-current loans, reflecting financial leverage and the cost of borrowed capital. By analyzing a firm's long-term borrowing indicators, an investor assesses the stability of the balance sheet structure. For Gilead Sciences, Inc. (GILD), such resources are critical for financing strategic alliances and licensing deals with biotechnology startups.

Competitors of Gilead Sciences, Inc. (GILD)

Company Long-Term Debts Cidara Corp CDTX|NVAX - Company Long-Term Debt|Company Long-Term Loans and Borrowings CVAC (CureVac NV)|Valneva Pharma (VALN) - Company Long-Term Debt|Company Long-Term Liabilities Vir Corp|SIGA (SIGA Technologies, Inc.) - Company Long-Term Debts|Company Long-Term Debts emergentbiosolutions.com|Company Long-Term Liabilities AVIR (Atea Pharmaceuticals, Inc.)|IVVD (invivyd.com) - Company Long-Term Loans and Borrowings|Enanta - Company Long-Term Liabilities|Inovio Pharma - Company Long-Term Debt|HilleVax, Inc. - Company Long-Term Debts|Long-Term Debt Volume kalaristx.com KLRS|dyadic.com (DYAI) - Company Long-Term Debt|NanoViricides - Company Long-Term Loans and Borrowings|Company Long-Term Liabilities TLPH|Company Long-Term Debts Cocrystal Pharma Corp|Company Long-Term Debt Traws Pharma, Inc. (TRAW)|Long-Term Debt Volume dwtx.com|Company Long-Term Debts QLGN (Qualigen Therapeutics, Inc.)|Long-Term Indebtedness AlloVir Inc|VBI Vaccines Inc - Company Long-Term Debts|Long-Term Debt Volume Virios Therapeutics VIRI|vaxart.com (VXRT) - Company Long-Term Debt